It mimics a hormone that helps control blood sugar and appetite
Baumel-Alterzon S, Katz LS, Brill G, Jean-Pierre C, Li Y, Tse I, et al (2022) Nrf2 regulates -cell mass by suppressing -cell death and promoting -cell proliferation
He stopped taking Ozempic in early October after his body began to reject food
| Risk Dimension | Evidence Quality | Severity if Realized | Practical Impact | |---|---|---|---| | Absorption interference (oral, same-time dosing) | Indirect/mechanistic | Moderate (reduced efficacy) | High: fixable with timing | | Direct chelation (glutathione binds alendronate) | None documented | Low | Low | | Pharmacodynamic antagonism (bone) | None documented | Potentially none or positive | Low | | Hepatic CYP interaction | Not applicable | None | None | | Renal clearance competition (IV glutathione) | Theoretical only | Unknown | Moderate precaution warranted | The dominant clinical concern is absorption interference, and it is entirely preventable with correct timing
Who can take them Wegovy is approved for adults with a BMI of 30+ or 27+ and a weight-related condition, like high blood pressure or high cholesterol